ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » West Virginia » Internal Medicine

Top Internal Medicine Prescribers in West Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MUSTAFA RAHIM M.D.

Internal Medicine

53,567

$3.36M

1124
527 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $62

ZAVEEN KUREISHY M.D.

Internal Medicine

30,908

$1.83M

849
663 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $62

SATHISHCHANDRA RAO M.D.

Internal Medicine

30,681

$1.8M

750
510 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

37%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $62

GOVINDBHAI PATEL MD

Internal Medicine

28,168

$1.7M

976
793 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $62

JOSEPH HASHEM MD

Internal Medicine

26,429

$1.6M

666
567 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $62

CHARLES MIRABILE M.D.

Internal Medicine

25,996

$1.1M

308
286 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

39%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $62

ROBERT TAYENGCO MD

Internal Medicine

25,596

$1.53M

560
415 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $62

PETER ANG M.D.

Internal Medicine

24,887

$1.38M

742
679 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $62

DAVID PATICK MD

Internal Medicine

24,754

$1.31M

810
664 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $62

CHRISTOPHER SKAGGS M.D.

Internal Medicine

24,049

$1.47M

854
661 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $62

GHALI IBRAHIM-BACHA MD

Internal Medicine

23,961

$1.41M

611
320 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

37%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $62

JOHN LILLY MD

Internal Medicine

23,336

$1.39M

878
704 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

32%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $62

SURAYIA HASAN MD

Internal Medicine

22,120

$1.38M

661
390 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $62

ARIF MALIK MD

Internal Medicine

21,828

$1.21M

636
485 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $62

IRVIN SNYDER DO

Internal Medicine

21,274

$1.14M

665
527 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $62

SURESH THOMAS MD

Internal Medicine

21,114

$1.09M

571
473 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $62

ASHISH SHETH MD

Internal Medicine

20,780

$1.16M

530
300 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $62

THOPSIE JAGANNATH MD

Internal Medicine

20,343

$1.15M

687
513 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $62

TIMOTHY SAXE M.D.

Internal Medicine

19,807

$1.35M

702
509 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $62

ALI KHAN M.D.

Internal Medicine

18,901

$1.3M

647
461 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $62

JEFFREY HOLMES MD

Internal Medicine

18,796

$1.22M

605
506 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $62

GARY HANSON MD

Internal Medicine

18,463

$750K

632
556 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $62

NARCISO TUANQUIN MD

Internal Medicine

18,447

$973K

426
280 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $62

WARD PAINE MD

Internal Medicine

18,358

$1.07M

725
601 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $62

EUGENIO MENEZ MD

Internal Medicine

18,038

$1M

470
372 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank